Federal Circuit / U.S. Court of Spec. Jurisdiction

Federal Circuit / U.S. Court of Spec. Jurisdiction
(incl: International Trade (Customs), Federal Claims, Armed Forces, Federal Adm. Agencies & Boards, Immigration, Tax, Gov. Personnel Appeals, Patent , Trademark, Veterans Appeals, etc.)

Custom text Title Organization
Jun
23
2018
Seeking Attorneys’ Fees Under the Patent Act? Early and Clear Notice of an Opposing Party’s Deficient Litigation Conduct Is a Prerequisite for a Successful Motion Squire Patton Boggs (US) LLP
Jun
22
2018
With its Vanda Pharma and Berkheimer memos, USPTO provides increased clarity around personalized medicine patent eligibility Mintz
Jun
20
2018
Recent Developments at the USPTO Covington & Burling LLP
Jun
19
2018
The Hobson's Choice Of The Hatch-Waxman Integrity Act Foley & Lardner LLP
Jun
15
2018
SAS "Ground" Rules Foley & Lardner LLP
Jun
14
2018
Appeals Court Rejects Insurers Risk Corridors Claims Mintz
Jun
11
2018
USPTO Vanda Memo Emphasizes Patent Eligibility Of Method Of Treatment Claims Foley & Lardner LLP
Jun
11
2018
Patent Venue Mandamus Has Its Limits Squire Patton Boggs (US) LLP
Jun
5
2018
PTAB Releases Frequently Asked Questions About The Implications Of SAS on AIA Trial Proceedings Foley & Lardner LLP
Jun
5
2018
Federal Circuit Finds Incorporation By Reference Inadequate For Priority Claim Foley & Lardner LLP
Jun
4
2018
Ex Parte Galloway – Berkheimer Meet s. 103 Schwegman, Lundberg & Woessner, P.A.
Jun
1
2018
SAS Institute: One Month In Foley & Lardner LLP
May
30
2018
The Expanded Scope of the Printed Matter Doctrine and Effect on “Mental Steps” Brinks Gilson & Lione
May
29
2018
Federal Circuit Holds Federal Circuit Law Applies to Patent Venue Challenges and Places Burden on Plaintiffs to Establish Venue Mintz
May
29
2018
Ex Parte Smith: What We’ve Got Here Is A Failure To Communicate! Schwegman, Lundberg & Woessner, P.A.
May
29
2018
Federal Circuit Finds INOMax Mental Steps Obvious As Ineligible Printed Matter Foley & Lardner LLP
May
28
2018
Medical Treatment Patent Claims Held Patentable Subject Matter Under the Alice/Mayo Section 101 Test Foley & Lardner LLP
May
25
2018
Ex parte Galloway – Two Correlations are Better than One Schwegman, Lundberg & Woessner, P.A.
May
23
2018
Federal Circuit clarifies that patent venue is proper only in a single judicial district within a multi-district state Mintz
May
22
2018
Ex Parte Stone: The “Disappearing Doctor” Leaves a Medical Device Behind Schwegman, Lundberg & Woessner, P.A.
May
22
2018
Recent Blockchain Patents of Note : May 22, 2018 Sheppard, Mullin, Richter & Hampton LLP
May
20
2018
Failure To Name Joint Inventors May Bar Patentability Squire Patton Boggs (US) LLP
May
17
2018
USPTO Seeks to Change BRI Patent Claim Construction Standard Polsinelli PC
May
17
2018
Some Processes Condensed for Patents Under Bayh-Dole Rule Changes Barnes & Thornburg LLP
May
17
2018
Willfulness Finding in EDTX Ruling in TCL v. Ericsson Illustrates the Risk to Accused Infringers of Failing to Investigate Allegations Mintz
May
16
2018
U.S. Corporate Defendants Incorporated In Multi-District States Reside Only In A Single District For Patent Venue Purposes Squire Patton Boggs (US) LLP
May
15
2018
Claim Construction Of An Enantiomeric Chemical Structure Foley & Lardner LLP
May
15
2018
Federal Circuit Rules That Plaintiff Bears Burden Of Proving Proper Patent Venue Squire Patton Boggs (US) LLP
May
14
2018
PTO Releases Revised Guidance on Compliance with Mayo/Alice Rule Schwegman, Lundberg & Woessner, P.A.
May
14
2018
Federal Circuit Rules That Foreign Defendants Cannot Rely On 28 U.S.C. § 1400(b) To Challenge Venue Brinks Gilson & Lione
May
11
2018
No Actual ‘Case or Controversy’ in Chromium Drinking Water Contamination Case Beveridge & Diamond PC
May
11
2018
USPTO Proposes Adopting Phillips Claim Construction Standard For IPRs, PGRs, and CBMs in Effort to Improve AIA Trials and Patent System Brinks Gilson & Lione
May
11
2018
Federal Circuit Finds Patent Venue Over Alien Corporations Is Proper In Any District Squire Patton Boggs (US) LLP
May
11
2018
The USPTO Proposes to Interpret Claims in Post-Grant Proceedings in the Same Way as the Federal Courts, and to Consider Prior Claim Constructions by Courts Squire Patton Boggs (US) LLP
May
10
2018
Personalized Medicine Gets a Boost from Federal Circuit’s Vanda Pharma Decision – PART II: Enforcement Mintz
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins